Categories
Uncategorized

Health Insurance That Doesn’t Cover the Bills Has Flooded the Market Under Trump

Early one Friday morning two years ago, David Diaz woke up his wife, Marisia, and told her he didn’t feel right. He asked her to pray with him. Their son called 911, and within minutes, Marisia was tailing an ambulance down the dirt road away from the couple’s house on the outskirts of Phoenix to […]

Categories
Uncategorized

The Human Capital Project, report from the World Bank

The Human Capital Project, a global effort to accelerate more and better investments in people for greater equity and economic growth. Why should countries invest in human capital? Can early health care and education prepare children to succeed and prosper as adults in a rapidly changing world? What are the barriers to nurturing human capital […]

Categories
Uncategorized

Trump discovers politics isn’t like business

Donald Trump is used to running private companies with him as President, and enjoying the Presidential power private companies provide. Now he finds being President of the United States isn’t the same as being President of Trump Organization. Republicans, who voted more than 60 times to repeal or alter Obamacare over the past few years […]

Categories
Uncategorized

Budget Office says Trump’s healthcare bill favors wealthy

Effects on Health Insurance Coverage To estimate the budgetary effects, Congressional Budget Office (CBO) and Joint Committee on Taxation (JCT) projected how the legislation would change the number of people who obtain federally subsidized health insurance through Medicaid, the nongroup market, and the employment-based market, as well as many other factors. CBO and JCT estimate that, in […]

Categories
Uncategorized

BC’s drug approval process dramatically altered

How stupid is the current BC government? Quite stupid. B.C.’s per-capita spending on drugs is currently 27 per cent less than the average level in the rest of the country, and this level likely to rise with changes proposed by government to allow far more input by drug companies when the government is considering drug […]